T1	PROC 46 75	Estudio multicéntrico abierto
T2	PROC 81 133	evaluar la eficacia, la seguridad y la tolerabilidad
T3	CHEM 181 191	adalimumab
#1	AnnotatorNotes T3	C1122087; adalimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T4	DISO 209 228	enfermedad de Crohn
#2	AnnotatorNotes T4	C0010346; Crohn Disease; Disease or Syndrome
T5	DISO 252 271	Enfermedad de Crohn
#3	AnnotatorNotes T5	C0010346; Crohn Disease; Disease or Syndrome
T6	PROC 403 419	ileocolonoscopia
T7	DISO 769 771	TB
#4	AnnotatorNotes T7	C0041296; Tuberculosis; Disease or Syndrome
T8	PROC 518 530	colonoscopia
#5	AnnotatorNotes T8	C0009378; colonoscopy; Diagnostic Procedure
T9	DISO 583 602	signos de displasia
T10	PROC 884 898	procedimientos
#6	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T11	DISO 755 767	tuberculosis
#7	AnnotatorNotes T11	C0041296; Tuberculosis; Disease or Syndrome
T12	PROC 840 850	profilaxis
#8	AnnotatorNotes T12	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T13	DISO 854 864	TB latente
#9	AnnotatorNotes T13	C1609538; Latent Tuberculosis; Disease or Syndrome
T14	PROC 154 168	administración
#10	AnnotatorNotes T14	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T15	CHEM 668 678	medicación
#11	AnnotatorNotes T15	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T16	DISO 608 623	proceso maligno
#12	AnnotatorNotes T16	C0006826; Malignant Neoplasms; Neoplastic Process
T17	Date 13 17	2013
T18	Date 134 147	a largo plazo
T19	LIVB 195 204	pacientes
#13	AnnotatorNotes T19	C0030705; Patients; Patient or Disabled Group
T20	LIVB 301 309	paciente
#14	AnnotatorNotes T20	C0030705; Patients; Patient or Disabled Group
T21	Date 423 435	la semana 12
T22	LIVB 469 477	paciente
#15	AnnotatorNotes T22	C0030705; Patients; Patient or Disabled Group
T24	Neg_cue 478 480	no
T25	Date 544 556	la semana 12
T26	LIVB 631 639	paciente
#16	AnnotatorNotes T26	C0030705; Patients; Patient or Disabled Group
T27	Neg_cue 640 642	no
T28	LIVB 727 735	Paciente
#17	AnnotatorNotes T28	C0030705; Patients; Patient or Disabled Group
T29	LIVB 810 818	paciente
#18	AnnotatorNotes T29	C0030705; Patients; Patient or Disabled Group
T30	Neg_cue 823 825	no
A1	Assertion T15 Negated
A2	Assertion T9 Negated
A3	Assertion T16 Negated
A4	Assertion T12 Negated
A5	Status T15 History_of
#19	AnnotatorNotes T1	C1709323; Open Label Study; Research Activity + C1096776; Multicenter Study; Research Activity
#20	AnnotatorNotes T2	C0511730; Identify product efficacy and safety issues; Health Care Activity + C3274448; Tolerability Study; Research Activity
#21	AnnotatorNotes T18	C0443252; Long-term; Temporal Concept
T23	Observation 486 511	inscribirse en el estudio
A6	Assertion T23 Negated
#22	AnnotatorNotes T23	C1302261; Patient eligible for clinical trial; Finding (?)
R1	Negation Arg1:T24 Arg2:T23	
R2	Negation Arg1:T24 Arg2:T9	
R3	Negation Arg1:T24 Arg2:T16	
R4	Negation Arg1:T27 Arg2:T15	
R5	Negation Arg1:T30 Arg2:T12	
T31	Quantifier_or_Qualifier 688 700	concomitante
A7	Assertion T31 Negated
#23	AnnotatorNotes T31	C0521115; Simultaneous; Temporal Concept 
R6	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T31	
R7	Negation Arg1:T27 Arg2:T31	
T32	Quantifier_or_Qualifier 169 177	repetida
#24	AnnotatorNotes T32	C0205341; Repeat; Functional Concept
R8	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T32	
R9	Used_for Arg1:T3 Arg2:T14	
R10	Overlap Arg1:T2 Arg2:T18	
R11	Experiences Arg1:T19 Arg2:T14	
R12	Experiences Arg1:T19 Arg2:T4	
T33	Observation 323 338	estado incluido
#25	AnnotatorNotes T33	C1278516; Patient participation status; Finding (?)
T34	Observation 341 381	completado satisfactoriamente el estudio
#26	AnnotatorNotes T34	C2732579; Completion of clinical trial; Finding
R15	Experiences Arg1:T20 Arg2:T6	
R16	Overlap Arg1:T6 Arg2:T21	
R17	Overlap Arg1:T8 Arg2:T25	
R20	Before Arg1:T8 Arg2:T23	
R23	Experiences Arg1:T22 Arg2:T8	
R24	Experiences Arg1:T22 Arg2:T9	
R25	Experiences Arg1:T22 Arg2:T16	
R26	Experiences Arg1:T26 Arg2:T15	
R27	Experiences Arg1:T28 Arg2:T11	
R28	Experiences Arg1:T28 Arg2:T7	
T35	Quantifier_or_Qualifier 773 779	activa
#27	AnnotatorNotes T35	C0679217; Active State; Idea or Concept
R29	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T35	
R30	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T35	
R31	Experiences Arg1:T29 Arg2:T12	
T36	PROC 791 798	estudio
A8	Status T36 History_of
#28	AnnotatorNotes T36	C0008976; Clinical Trials; Research Activity
R32	Overlap Arg1:T11 Arg2:T36	
R33	Overlap Arg1:T7 Arg2:T36	
R34	Experiences Arg1:T29 Arg2:T13	
R35	Experiences Arg1:T29 Arg2:T10	
R37	Before Arg1:T12 Arg2:T13	
A9	Experiencer T19 Patient
A10	Experiencer T20 Patient
A11	Experiencer T22 Patient
A12	Experiencer T26 Patient
A13	Experiencer T28 Patient
A14	Experiencer T29 Patient
